Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes-Reference-Cited by-同舟云学术

Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes

Published:2013-08-19 Issue:1 Volume:16 Page:57-62
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Koehler G.¹,Treiber G.¹,Wutte A.¹,Korsatko S.¹,Mader J. K.¹,Semlitsch B.¹,Pieber T. R.¹²

Affiliation:

1. Department of Internal Medicine, Division of Endocrinology and Metabolism; Medical University of Graz; Graz Austria

2. Joaneum Research; HEALTH-Institute of Biomedicine and Health Science; Graz Austria

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12178/fullpdf

Reference25 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group;The Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

2. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial;Goff;Am J Cardiol,2007

3. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes;Heise;Diabetes,2004

4. New insulins in the treatment of diabetes mellitus;Lindholm;Best Pract Res Clin Gastroenterol,2002

5. Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy;Pieber;Diabet Med,2007

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy for Type 1 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-02-16

2. Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 4. Auflage 2018);Diabetologie und Stoffwechsel;2023-10

3. Hypoglycemic Agents and Anesthetic Techniques to Ameliorate Stress Hyperglycemia in Critically Ill Patients: A Systematic Review;Journal of Research in Pharmacy Practice;2023-07

4. Treatment of type 1 diabetes;Die Diabetologie;2023-05-08

5. Therapie des Typ-1-Diabetes;Diabetes aktuell;2023-02